Using HIF-1α as a marker for hypoxia14, it has been observed that approximately 25 mm Hg22,23 hypoxic tumors are associated with a more aggressive phenotype24, increased risk of metastasis5, increased resistance to radiotherapy and chemotherapy25, and induced cancer immune suppression26–28. This evidence concerns the gene HIF1A and cancer.